Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 81, Issue 1, 2004, Pages 120-125

  Farah Eways, Lisa ^b   Reyna, Rosario ^b   Knochenhauer, Eric S ^b   Bartolucci, Alfred A ^b,c   Azziz, Ricardo ^a,b,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Adrenal; Glucose action; Insulin resistance; Polycystic ovary syndrome; Steroidogenesis

Indexed keywords

17 HYDROXYPREGNENOLONE; ANDROSTENEDIONE; CORTICOTROPIN; GLUCOSE; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; PRASTERONE; STEROID;

ADRENAL CORTEX FUNCTION; ADULT; ARTICLE; BIOSYNTHESIS; BODY MASS; CALCULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOTROPIN TEST; FEMALE; HORMONE ACTION; HUMAN; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MEASUREMENT; OVARY POLYCYSTIC DISEASE; PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; STEROIDOGENESIS; UNIVERSITY HOSPITAL;

EID: 0347356256     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.05.008     Document Type: Article

References (53)

1. Knochenhauer E.S., Key T.J., Khasar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovarian syndrome in unselected black and white women of the Southeastern United States a prospective study . J Clin Endocrinol Metab. 83:1998;3078-3082.
2. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 85:2000;2434-2438.
3. Wild R.A., Umstot E.S., Andersen R.N., Ranney G.B., Givens J.R. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol. 146:1983;602-606.
4. Carmina E., Koyama T., Chang L., Stanczyk F., Lobo R. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 167:1992;1807-1812.
5. Moran C., Knochenhauer E.S., Boots L.R., Azziz R. Adrenal androgen excess in hyperandrogenism relation to age and body mass . Fertil Steril. 71:1999;671-674.
6. Azziz R., Black V., Hines G.A., Fox L.M., Boots L.R. Adrenal androgen excess in the polycystic ovary syndrome sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis . J Clin Endocrinol Metab. 83:1998;2317-2323.
7. Ovalle F., Azziz R. Insulin resistance, the polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 77:2002;1095-1105.
8. Barbieri R.L., Makris A., Randall R.W., Daniels G., Kistner R.W., Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma from women with hyperandrogenism. J Clin Endocrinol Metab. 62:1986;904-910.
9. Nestler J.E., Jakubowicz D.J., Evans W.S., Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 338:1998;1876-1880.
10. DeClue T.J., Shah S.C., Marchese M., Malone J.I. Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female. J Clin Endocrinol Metab. 72:1991;1308-1311.
11. Nestler J.E., Beer N.A., Jakubowicz D.J., Colombo C., Beer R.M. Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men. J Clin Endocrinol Metab. 80:1995;700-706.
12. Beer N.A., Jakubowicz D.J., Beer R.M., Nestler J.E. Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. J Clin Endocrinol Metab. 79:1994;1077-1081.
13. Nestler J.E., Kahwash Z. Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. J Clin Endocrinol Metab. 94:1994;1484-1489.
14. Jakubowicz D.J., Beer N.A., Beer R.M., Nestler J.E. Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. J Clin Endocrinol Metab. 80:1995;3373-3376.
15. Lavallee B., Provost P.R., Kahwash Z., Nestler J.E., Belanger A. Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol (Oxf). 46:1997;93-100.
16. Schriock E.D., Buffington C.K., Hubert G.D., Kurtz B.R., Kitabchi A.E., Buster J.E., et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab. 66:1988;1329-1331.
17. Hubert G.D., Schriock E.D., Givens J.R., Buster J.E. Suppression of circulating delta 4-androstenedione and dehydroepiandrosterone sulfate during oral glucose tolerance test in normal females. J Clin Endocrinol Metab. 73:1991;781-784.
18. Buyalos R.P., Geffner M.E., Azziz R., Judd H.L. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome. Hum Reprod. 12:1997;1138-1141.
19. Falcone T., Finegood D.T., Fantus J.G., Morris D. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women. J Clin Endocrinol Metab. 71:1990;1653-1657.
20. Diamond M.P., Grainger D.A., Laudano A.J., Starick-Zych K., DeFronzo R.A. Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. J Clin Endocrinol Metab. 72:1991;883-887.
21. Pasquali R., Casimirri F., Venturoli S., Paradisi R., Mattioli L., Capelli M., et al. Insulin resistance in patients with polycystic ovaries its relationship to body weight and androgen levels . Acta Endocrinol (Copenh). 104:1983;110-116.
22. Smith S., Ravnikar V.A., Barbieri R.L. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil Steril. 48:1987;72-77.
23. Alper M.M., Garner P.R. Elevated serum dehydroepiandrosterone sulfate levels in patients with insulin resistance, hirsutism, and acanthosis nigricans. Fertil Steril. 47:1987;255-258.
24. Martikainen H., Salmela P., Nuojua-Huttunen S., Perala J., Leinonen S., Knip M., et al. Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil Steril. 66:1996;564-570.
25. Lanzone A., Fulghesu A.M., Guido M., Fortini A., Caruso A., Mancuso S. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome relationship with insulin secretion . Fertil Steril. 58:1992;296-301.
26. Azziz R., Bradley E.L. Jr, Potter H.D., Parker C.R. Jr, Boots L.R. Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. Am J Obstet Gynecol. 172:1995;1251-1256.
27. Vrbiklova J., Hill M., Starka L., Vondra K., Sulcova J., Snajderova M., et al. An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 108:2000;455-462.
28. Elkind-Hirsch K.E., Valdes C.T., McConnell T.G., Malinak L.R. Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women. Fertil Steril. 55:1991;486-491.
29. Moghetti P., Castello R., Negri C., Tosi F., Spiazzi G.G., Brun E., et al. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women apparent relative impairment of 17,20-lyase activity . J Clin Endocrinol Metab. 81:1996;881-886.
30. Zawadzki J.K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Dunaif A., Givens J.R., Haseltine F., Merriam G.R. Polycystic ovary syndrome. 1992;377-384 Blackwell Scientific, Boston.
31. Hatch R., Rosenfield R.L., Kim M.H., Tredway D. Hirsutism implications, etiology, and management . Am J Obstet Gynecol. 140:1981;815-830.
32. Azziz R., Hincapie L.A., Knochenhauer E.S., Dewailly D., Fox L., Boots L.R. Screening for 21-hydroxylase deficient non-classic adrenal hyperplasia among hyperandrogenic women a prospective study . Fertil Steril. 72:1999;915-925.
33. Woods K.S., Reyna R., Azziz R. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. Fertil Steril. 77:2002;1125-1127.
34. Bergman R.N., Hope I.D., Yang Y.J., Watanabe R.M., Meador M.A., Youn J.H., et al. Assessment of insulin sensitivity in vivo a critical review . Diab Metab Rev. 5:1989;411-429.
35. Azziz R., Bradley E.L. Jr, Potter H.D., Boots L.R. 3β- hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am J Obstet Gynecol. 168:1993;889-895.
36. Azziz R., Bradley E.L. Jr, Potter H.D., Boots L.R. Adrenal androgen excess in women lack of a role for 17-hydroxylase and 17,20-lyase dysregulation . J Clin Endocrinol Metab. 80:1995;400-405.
37. Boots L.R., Potter S., Potter H.D., Azziz R. Measurement of total serum testosterone level using commercial kits high degree of variability and inaccuracy . Fertil Steril. 69:1997;286-292.
38. Pearlman W.I., Crepy O. Steroid-protein interaction with particular reference to testosterone binding by human serum. J Biol Chem. 242:1967;182-189.
39. Pacini G., Bergman R.N. MINMOD a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test . Comput Methods Programs Biomed. 23:1986;113-122.
40. Falcone T., Little A.B., Morris D. Impaired glucose effectiveness in patients with polycystic ovary syndrome. Hum Reprod. 7:1992;922-925.
41. Cagnacci A., Paoletti A.M., Arangino S., Melis G.B., Volpe A. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism. Hum Reprod. 14:1999;893-897.
42. Elkind-Hirsch K.E., Valdes C.T., Malinak L.R. Insulin resistance improves in hyperandrogenic women treated with Lupron. Fertil Steril. 60:1993;634-641.
43. Buffington C.K., Givens J.R., Kitabchi A.E. Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women. Metabolism. 43:1994;584-590.
44. Lobo R.A., Goebelsmann U., Brenner P.F., Mishell D.R. Jr. The effect of estrogen on adrenal androgens in oopherectomized women. Am J Obstet Gynecol. 142:1982;471-478.
45. Ditkoff E.C., Fruzzetti F., Chang L., Stancyzk F.Z., Lobo R.A. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome. J Clin Endocrinol Metab. 80:1995;603-607.
46. Carmina E., Gonzalez F., Vidali A., Stanczyk F.Z., Ferin M., Lobo R.A. The contributions of estrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome. Hum Reprod. 14:1999;307-311.
47. Gonzalez F., Hatala D., Speroff L. Adrenal and ovarian steroid responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Am J Obstet Gynecol. 165:1991;535-545.
48. Fruzzetti F., De Lorenzo D., Ricci C., Teti G. Ovarian influence on adrenal androgen secretion in the PCOS. Fertil Steril. 63:1995;734-741.
49. Azziz R., Rittmaster R.S., Fox L.M., Bradley E.L., Potter H.D., Boots L.R. Role of the ovary in the adrenal androgen excess of hyperandrogenic women. Fertil Steril. 69:1998;851-859.
50. Quon M.J., Cochran C., Taylor S.I., Eastman R.C. Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes. 43:1994;890-896.
51. Finegood D.T., Tzur D. Reduced glucose effectiveness associated with reduced insulin release an artifact of the minimal-model method . Am J Physiol. 271:1996;E485-495.
52. Cobelli C., Bettini F., Caumo A., Quon M.J. Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling. Am J Physiol. 275:1998;E1031-1036.
53. Ader M., Ni T.C., Bergman R.N. Glucose effectiveness assessed under dynamic and steady state conditions. J Clin Invest. 99:1997;1187-1199.